Ben R. Taylor
Chief Financial Officer, TYME TECHNOLOGIES, INC.
Companies
- Recursion PharmaceuticalsChief financial officer Dec 2, 2024 to now1
- TYME TECHNOLOGIES, INC.Chief financial officer Jul 27, 2017 to May 18, 20202
- TYME TECHNOLOGIES, INC.President Jul 27, 2017 to May 18, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Recursion Pharmaceuticals RXRX1,071,462 shares3$3.9M at $3.63Sep 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 15, 2026Shares withheld for tax 5,396 shares at $3.41 of Recursion Pharmaceuticals3
- Aug 17, 2026Shares withheld for tax 25,018 shares at $3.16 of Recursion Pharmaceuticals4
- Jun 15, 2026Shares withheld for tax 5,396 shares at $3.15 of Recursion Pharmaceuticals5
- May 15, 2026Shares withheld for tax 25,018 shares at $3.04 of Recursion Pharmaceuticals6
- Apr 6, 2026Shares withheld for tax 48,028 shares at $3.11 of Recursion Pharmaceuticals7
- Mar 17, 2026Sold 7,956 shares at $3.39 of Recursion Pharmaceuticals8
- Mar 16, 2026Shares withheld for tax 7,075 shares at $3.42 of Recursion Pharmaceuticals8
- Feb 18, 2026Sold 13,426 shares at $3.08 of Recursion Pharmaceuticals9
- Feb 17, 2026Shares withheld for tax 11,908 shares at $3.49 of Recursion Pharmaceuticals9
- Feb 6, 2026Shares withheld for tax 11,400 shares at $3.98 of Recursion Pharmaceuticals10
- Feb 6, 2026Granted 24,254 shares of Recursion Pharmaceuticals10
- Feb 6, 2026Granted 446,279 shares of Recursion Pharmaceuticals10
- Dec 29, 2025Sold 21,383 shares at $4.18 of Recursion Pharmaceuticals11
- Dec 15, 2025Shares withheld for tax 7,057 shares at $4.33 of Recursion Pharmaceuticals12
- Nov 25, 2025Shares withheld for tax 2,271 shares at $4.03 of Recursion Pharmaceuticals13
- Nov 17, 2025Shares withheld for tax 11,908 shares at $4.14 of Recursion Pharmaceuticals14
- Sep 15, 2025Shares withheld for tax 7,057 shares at $4.83 of Recursion Pharmaceuticals15
- Aug 15, 2025Shares withheld for tax 11,908 shares at $5.64 of Recursion Pharmaceuticals16
- Jun 16, 2025Shares withheld for tax 7,057 shares at $4.92 of Recursion Pharmaceuticals17
- May 15, 2025Shares withheld for tax 11,908 shares at $4.25 of Recursion Pharmaceuticals18
- Apr 1, 2025Shares withheld for tax 26,571 shares at $5.10 of Recursion Pharmaceuticals19
- Mar 17, 2025Shares withheld for tax 7,057 shares at $6.84 of Recursion Pharmaceuticals20
- Feb 18, 2025Shares withheld for tax 10,879 shares at $10.64 of Recursion Pharmaceuticals21
- Feb 3, 2025Shares withheld for tax 6,544 shares at $7.25 of Recursion Pharmaceuticals22
- Feb 3, 2025Granted 13,922 shares of Recursion Pharmaceuticals22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Aug 18, 2026
- 5SEC EDGARForm 4 filed Jun 17, 2026
- 6SEC EDGARForm 4 filed May 19, 2026
- 7SEC EDGARForm 4 filed Apr 8, 2026
- 8SEC EDGARForm 4 filed Mar 18, 2026
- 9SEC EDGARForm 4 filed Feb 19, 2026
- 10SEC EDGARForm 4 filed Feb 10, 2026
- 11SEC EDGARForm 4 filed Dec 30, 2025
- 12SEC EDGARForm 4 filed Dec 17, 2025
- 13SEC EDGARForm 4 filed Nov 26, 2025
- 14SEC EDGARForm 4 filed Nov 19, 2025
- 15SEC EDGARForm 4 filed Sep 17, 2025
- 16SEC EDGARForm 4 filed Aug 19, 2025
- 17SEC EDGARForm 4 filed Jun 18, 2025
- 18SEC EDGARForm 4 filed May 19, 2025
- 19SEC EDGARForm 4 filed Apr 3, 2025
- 20SEC EDGARForm 4 filed Mar 19, 2025
- 21SEC EDGARForm 4 filed Feb 20, 2025
- 22SEC EDGARForm 4 filed Feb 5, 2025